GMNN and medulloblastoma: These effects were observed both in a mouse in vivo model of medulloblastoma and in human medulloblastoma cells, and resulted in increased survival in the mouse model, while Gmnn deficient medulloblastoma cells were also sensitized to treatment with the Topo IIα inhibitor etoposide.